VPH — Valeo Pharma Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- CA$4.44m
- CA$67.40m
- CA$53.91m
Brief: Valeo Pharma Says Submitted Hesperco Natural Product License Application For Approval To Health Canada
Brief: Valeo Pharma Reports Its 2020 Second Quarter Results
Brief: Valeo Pharma Licenses Canadian Rights to Ametop™ Gel from Alliance Pharma
Brief: Valeo Pharma Has Submitted A New Drug Submission With Health Canada Seeking Marketing Approval Of Redesca
Brief: Valeo Pharma Signs Licensing Agreement With Pharmamar To Commercialize Yondelis In Canada
Brief: Pharma Mar Signs Agreement With Valeo Pharma To Commercialize Yondelis In Canada
Brief: Valeo Pharma Announces Filing Of New Drug Submission For Low Molecular Weight Heparin In Canada
Brief: Valeo Pharma Announces Change Of Auditor
Brief: Valeo Pharma Appoints Michel Trudeau To Its Board Of Directors
Brief: Newron: Zambon And Valeo Pharma Launch Onstryv For Parkinson's disease In Canada